A new role for astrocytes: β-Amyloid homeostasis and degradation

Trends in Molecular Medicine

Volumn 9, Issue 7, 2003, Pages 281-282

  Nicoll, James A R ^a   Weller, Roy O ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ASTROCYTE; CELL MIGRATION; HOMEOSTASIS; NERVE CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW;

EID: 0041926623     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00109-6     Document Type: Short Survey

References (11)

1. Selkoe, D.J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766
2. Wyss-Coray, T. et al. (2003) Adult mouse astrocytes degrade amyloidin vitro and in situ. Nat. Med. 9, 453-457
3. Lue, L.F. et al. (1999) Soluble amyloid β-peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862
4. McLean, C.A. et al. (1999) Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860-866
5. Iwata, N. et al. (2002) Region-specific reduction of Aβ-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 70, 493-500
6. Evin, G. and Weidemann, A. (2002) Biogenesis and metabolism of Alzheimer's disease Aβ amyloid peptides. Peptides 23, 1285-1297
7. 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499
8. Weller, R.O. et al. (2002) Cerebrovacular disease is a major factor in the failure of elimination of Aβ from the human brain: implications for therapy of Alzheimer's disease. Ann. N. Y. Acad. Sci. 977, 162-168
9. Van Dorpe, J. et al. (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am. J. Pathol. 157, 1283-1298
10. Bard, F. et al. (2000) Peripherally administered antibodies against amyloid-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916-919
11. Nicoll, J.A.R. et al. (2003) Neuropathology ofhuman Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med. 9, 448-452